Article
Pathogenicity assessment of a TSC2 c.2966+1G>A splice site variant in vaginal adenocarcinoma
2026-01-16
Abstract excerpt
<h4>ABSTRACT</h4> Clinical sequencing of a vaginal adenocarcinoma specimen yielded a reported TSC2 variant which was classified as splice-modulating loss-of-function, prompting consideration of a clinical trial for tumors with TSC2 loss. Literature review suggested that germline alterations affecting this particular exon are considered non-pathogenic, raising concern about the initial somatic variant interpretati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e3137f8-cf28-5249-81fe-419a3e1cc2e8
- DOI
- 10.64898/2025.12.31.25343109
